Monday, Dec 18, 2017
engineered enzymes for better healthcare

We have produced a portfolio of robust designer enzymes (amino acid dehydrogenases) using structural information and genetic techniques. These will handle a wide range of commercially-interesting substrates. The enzymes can be used in either one of two ways to produce chiral amino acid building blocks for drug synthesis. If the keto acid is most readily available by chemical synthesis, these enzymes will introduce the chiral amino group with 100% fidelity.  If instead a 50:50 racemic mixture of D and L amino acids is more cheaply available, the enzymes can be used in two stages to effect a total separation of the two isomers.

The Technology               Product Range                Advantages

Value of the Technology        Relative Patents / Publications

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...